Filters
New filters have been added to narrow your search: Test target, to filter by number of genes; Genes and Conditions, to search by gene symbol or condition name; and Labs, to search by a laboratory name.
Other countries
Labs matching your search
52 labs with tests matching your search
Results:
504 genetic tests from 52 labs with tests matching your search
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods | |
|---|---|---|---|---|
| 1 | 1 |
| ||
| 1 | 1 |
| ||
| 1 | 1 |
| ||
Prostate cancer, susceptibility to, 176807, Autosomal dominant (Familial prostate cancer) (MLPA) | 1 | 1 |
| |
| 1 | 1 |
| ||
| 1 | 1 |
| ||
| 1 | 1 |
| ||
Prostate cancer, 176807, Autosomal dominant (Familial prostate cancer) (MLPA) | 1 | 1 |
| |
| 1 | 1 |
| ||
| 1 | 1 |
| ||
| 1 | 1 |
| ||
| 1 | 1 |
| ||
| 1 | 1 |
| ||
| 1 | 18 |
| ||
| 1 | 1 |
| ||
Prostate cancer, somatic, 176807 (MAD1L1 gene) (Sequence Analysis-All Coding Exons) (Postnatal) | 1 | 1 |
| |
Prostate cancer, familial, susceptibility to, 176807, Autosomal dominant (MLPA) | 1 | 1 |
| |
| 1 | 1 |
| ||
| 1 | 1 |
| ||
Prostate cancer, somatic, 176807 (KLF6 gene) (Sequence Analysis-All Coding Exons) (Postnatal) | 1 | 1 |
|
504 tests from 52 labs
Page 1 of 26❯Prostate cancer, susceptibility to, 176807, Autosomal dominant (Familial prostate cancer) (CD82 gene) (Sequence Analysis-All Coding Exons) (Postnatal) by Intergen Genetics and Rare Diseases Diagnosis Center
1 condition, 1 gene
1 condition, 1 gene
Prostate cancer, susceptibility to, 176807, Autosomal dominant (Familial prostate cancer) (MXI1 gene) (Sequence Analysis-All Coding Exons) (Postnatal) by Intergen Genetics and Rare Diseases Diagnosis Center
1 condition, 1 gene
1 condition, 1 gene
Prostate cancer, susceptibility to, 176807, Autosomal dominant (Familial prostate cancer) (AR gene) (Sequence Analysis-All Coding Exons) (Postnatal) by Intergen Genetics and Rare Diseases Diagnosis Center
1 condition, 1 gene
1 condition, 1 gene
Prostate cancer, susceptibility to, 176807, Autosomal dominant (Familial prostate cancer) (MLPA) by Intergen Genetics and Rare Diseases Diagnosis Center
1 condition, 1 gene
1 condition, 1 gene
Prostate cancer, hereditary, 176807, Autosomal dominant (Familial prostate cancer) (MSR1 gene) (Sequence Analysis-All Coding Exons) (Postnatal) by Intergen Genetics and Rare Diseases Diagnosis Center
1 condition, 1 gene
1 condition, 1 gene
Prostate cancer, progression of, 176807, Autosomal dominant (Familial prostate cancer) (HIP1 gene) (Sequence Analysis-All Coding Exons) (Postnatal) by Intergen Genetics and Rare Diseases Diagnosis Center
1 condition, 1 gene
1 condition, 1 gene
Prostate cancer, 176807, Autosomal dominant (Familial prostate cancer) (BRCA2 gene) (Sequence Analysis-All Coding Exons) (Postnatal) by Intergen Genetics and Rare Diseases Diagnosis Center
1 condition, 1 gene
1 condition, 1 gene
Prostate cancer, 176807, Autosomal dominant (Familial prostate cancer) (MLPA) by Intergen Genetics and Rare Diseases Diagnosis Center
1 condition, 1 gene
1 condition, 1 gene
Prostate cancer, susceptibility to, 176807, Autosomal dominant (Familial prostate cancer) (CDH1 gene) (Sequence Analysis-All Coding Exons) (Postnatal) by Intergen Genetics and Rare Diseases Diagnosis Center
1 condition, 1 gene
1 condition, 1 gene
Prostate cancer 1, 601518, Autosomal dominant; HPC1 (Familial prostate cancer) (RNASEL gene) (Sequence Analysis-All Coding Exons) (Postnatal) by Intergen Genetics and Rare Diseases Diagnosis Center
1 condition, 1 gene
1 condition, 1 gene
Prostate cancer, hereditary, 2, susceptibility to, 614731; HPC2 (Familial prostate cancer) (ELAC2 gene) (Sequence Analysis-All Coding Exons) (Postnatal) by Intergen Genetics and Rare Diseases Diagnosis Center
1 condition, 1 gene
1 condition, 1 gene
Prostate cancer, hereditary, 13, 611928; HPC13 (Familial prostate cancer) (MSMB gene) (Sequence Analysis-All Coding Exons) (Postnatal) by Intergen Genetics and Rare Diseases Diagnosis Center
1 condition, 1 gene
1 condition, 1 gene
geneType for prostate cancer by Rhythm Biosciences/IchorDX, Rhythm Biosciences Ltd
1 condition, 1 gene
1 condition, 1 gene
Hereditary Prostate Cancer Panel by Mayo Clinic Laboratories, Mayo Clinic
1 condition, 18 genes
1 condition, 18 genes
Prostate cancer/brain cancer susceptibility, somatic, 603688 (EPHB2 gene) (Sequence Analysis-All Coding Exons) (Postnatal) by Intergen Genetics and Rare Diseases Diagnosis Center
1 condition, 1 gene
1 condition, 1 gene
Prostate cancer, somatic, 176807 (MAD1L1 gene) (Sequence Analysis-All Coding Exons) (Postnatal) by Intergen Genetics and Rare Diseases Diagnosis Center
1 condition, 1 gene
1 condition, 1 gene
Prostate cancer, familial, susceptibility to, 176807, Autosomal dominant (MLPA) by Intergen Genetics and Rare Diseases Diagnosis Center
1 condition, 1 gene
1 condition, 1 gene
Prostate cancer, susceptibility to, somatic, 176807 (ZFHX3 gene) (Sequence Analysis-All Coding Exons) (Postnatal) by Intergen Genetics and Rare Diseases Diagnosis Center
1 condition, 1 gene
1 condition, 1 gene
Prostate cancer, familial, susceptibility to, 176807, Autosomal dominant (CHEK2 gene) (Sequence Analysis-All Coding Exons) (Postnatal) by Intergen Genetics and Rare Diseases Diagnosis Center
1 condition, 1 gene
1 condition, 1 gene
Prostate cancer, somatic, 176807 (KLF6 gene) (Sequence Analysis-All Coding Exons) (Postnatal) by Intergen Genetics and Rare Diseases Diagnosis Center
1 condition, 1 gene
1 condition, 1 gene
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.